{"transactions":[{"id":3457995,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":155914,"kind":"organization","name":"6 Dimensions Capital, L.P.","position":1,"cik":"0001717958","reported_name":"6 Dimensions Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-07-22T16:32:02.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":3087500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":441071},"source":{"system":"sec-edgar","filing":"0001104659-19-041307","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1717958/000110465919041307/a4.xml","form_type":"4"}},{"id":3457994,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":155914,"kind":"organization","name":"6 Dimensions Capital, L.P.","position":1,"cik":"0001717958","reported_name":"6 Dimensions Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T16:32:02.000Z","date":"2019-07-22","kind":"purchase","acquired":true,"shares":118750,"price":16,"value":1900000.0,"ownership":{"direct":true},"balance_after":559821,"source":{"system":"sec-edgar","filing":"0001104659-19-041307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1717958/000110465919041307/a4.xml","form_type":"4"}},{"id":3457993,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":155914,"kind":"organization","name":"6 Dimensions Capital, L.P.","position":1,"cik":"0001717958","reported_name":"6 Dimensions Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T16:32:02.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":441071,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date."}],"balance_after":441071,"source":{"system":"sec-edgar","filing":"0001104659-19-041307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717958/000110465919041307/a4.xml","form_type":"4"}}]}